Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

General discussion, page-1500

First 1500 Last

Share
Profile

Follow
Exalted

1,869 Posts.

1472

16/09/20

12:29

Post #: 47383367
Share

Originally posted by The ruster: ↑

Well J as others have posted the medical tar, here and board is excellent and there are several trials on the horizon that would make the company and the oil sales will also likely increase . In relation to the ARDS trial phase one was successful , in vitro was successful so one would expect that phase 2 will be successful and once boxes ticked approval obtained the SP will reflect the rerate .

The point is that the BOD has not put a foot wrong they have delivered what they have said they would to date in very trying times of COVID and the ARDS results announced to date are excellent . So imo there is no indication that the results will not be positive and for the trial not to be successful and given what we know to date on the contrary it should follow through and on the company establishing efficacy of any of the trials it will re rate massively imo .

Excellent risk reward and imo undervalued on the oil sales alone at these levels . I am happy to be patient and to be invested in this company ,but each has to make their own decision according to their risk profile .AIMO .

Expand

Options overhang aint done yet lol. Some pretty obvious trades today, someone buys 170K IHLOB and immediately sells the exact same amount on IHL seconds after. Easy 4 pips there.

As expiry looms I'm expecting an enormous flurry of options conversions. Dont forget that our directors are all in the Top 20. Will be a huge display of confidence and strength when they convert their substantial holdings.

IHL Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held
17 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 18,936 more messages in this thread...

First 1500 Last

Add IHL (ASX) to my watchlist

General discussion, page-1500

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Featured News